tiprankstipranks
Oncolys BioPharma, Inc. (JP:4588)
:4588
Japanese Market

Oncolys BioPharma, Inc. (4588) Income Statement

Compare
0 Followers

Oncolys BioPharma, Inc. Income Statement

Last quarter (Q1 2024), Oncolys BioPharma, Inc.'s total revenue was ¥0.00, a decrease of -100.00% from the same quarter last year. In Q1, Oncolys BioPharma, Inc.'s net income was ¥-364.23M. See Oncolys BioPharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
¥ 63.04M¥ 976.18M¥ 642.49M¥ 314.18M¥ 1.30B
Gross Profit
¥ 30.61M¥ 338.49M¥ 198.80M¥ 236.11M¥ 1.19B
Operating Expenses
¥ 1.96B¥ 1.54B¥ 1.65B¥ 1.91B¥ 1.70B
Depreciation and Amortization
¥ 2.29M¥ 914.00K¥ 6.49M¥ 4.89M¥ 3.11M
EBITDA
¥ -1.93B¥ -1.14B¥ -1.60B¥ -2.08B¥ -901.53M
Operating Income
¥ -1.93B¥ -1.20B¥ -1.45B¥ -1.67B¥ -511.46M
Other Income/Expenses
¥ -5.59M¥ 58.50M¥ -157.16M¥ -416.71M¥ -397.13M
Pretax Income
¥ -1.94B¥ -1.15B¥ -1.61B¥ -2.09B¥ -908.59M
Net Income
¥ -1.94B¥ -1.15B¥ -1.62B¥ -2.10B¥ -912.35M
Per Share Metrics
Basic EPS
¥ -108.92¥ -66.31¥ -95.50¥ -145.58¥ -65.55
Diluted EPS
¥ -108.92¥ -66.31¥ -95.50¥ -145.58¥ -65.55
Weighted Average Shares Outstanding
17.80M 17.33M 16.92M 14.39M 13.92M
Weighted Average Shares Outstanding (Diluted)
17.80M 17.33M 16.92M 14.39M 13.92M
Currency in JPY

Oncolys BioPharma, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis